Pineal beta adrenergic receptor: correlation of binding of 3H-l- alprenolol with stimulation of adenylate cyclase

M Zatz, JW Kebabian, JA Romero, RJ Lefkowitz and J Axelrod

3H-l-Alprenolol, a potent competitive beta adrenergic antagonist, binds to sites in rat pineal gland membranes. The properties of these binding sites were compared to those of the receptors which mediate the beta adrenergic activation of pineal adenylate cyclase. Both sites are highly stereospecific. The l-stereoisomers of alprenolol and propranolol were at least two orders of magnitude more potent than the d-stereoisomers in inhibiting isoproterenol-stimulated adenylate cyclase or 3H-l-alprenolol binding. The dissociation constants (Kd) of the l-stereoisomers of both alprenolol and propranolol were 10 to 22 nM as determined by competition for binding sites or by inhibition of isoproternol-stimulated adenylate cyclase. Beta adrenergic agonists which stimulated adenylate cyclase also competitively inhibited the binding of 3H-l-alprenolol. They showed the same order of potency (isoproterenol greater than norepinephrine greater than or equal to epinephrine) and the same individual affinities in the two systems. Alpha adrenergic blockers were ineffective in inhibiting either adenylate cyclase stimulation or 3H-l-alprenolol binding. Isoproternol stimulation of adenylate cyclase acrivity, and 3H-l-alprenolol binding, were rapid and rapidly reversible. The 3H-l-alprenolol binding sites were saturable and bound 0.6 pmol of ligand per mg of added protein. The data suggest that the binding of 3H-l-alprenolol occurs at sites indistinguishable from the pineal beta adrenergic receptor.

Volume 196, Issue 3, pp. 714-722, 03/01/1976
Copyright © 1976 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				V. Simonneaux and C. Ribelayga Generation of the Melatonin Endocrine Message in Mammals: A Review of the Complex Regulation of Melatonin Synthesis by Norepinephrine, Peptides, and Other Pineal Transmitters Pharmacol. Rev., June 1, 2003; 55(2): 325 - 395. [Abstract] [Full Text] [PDF]

				S.A. Checkley, F. Winton, T. Corn, C. Franey, and J. Arendt Effects of a phosphodiesterase inhibitor (Rolipram) on the urinary excretion of 6-sulphatoxy melatonin in man J Psychopharmacol, January 1, 1987; 1(1): 20 - 22. [Abstract] [PDF]

				S.A. Checkley and S.B.G. Park The psychopharmacology of the human pineal J Psychopharmacol, January 1, 1987; 1(2): 109 - 125. [Abstract] [PDF]

				R. Reiter, B. Richardson, L. Johnson, B. Ferguson, and D. Dinh Pineal melatonin rhythm: reduction in aging Syrian hamsters Science, December 19, 1980; 210(4476): 1372 - 1373. [Abstract] [PDF]

				M Gallagher, B. Kapp, R. Musty, and P. Driscoll Memory formation: evidence for a specific neurochemical system in the amygdala Science, October 28, 1977; 198(4315): 423 - 425. [Abstract] [PDF]